Skip to main content
. 2011 Jun 1;1:10.3402/pba.v1i0.7202. doi: 10.3402/pba.v1i0.7202

Table 3.

Clinicopathological data from B6 mouse presented in Figures 2B, 5C, and 5D and CB6F1 mouse presented in 3B, 3D, and 4C

B6 Female Figs. 2B and 5C,D CB6F1 Male Figs. 3B,D and 4C Reference valuesa
Complete blood count
 WBC, K/ul 2.5 14.8 5.1–11.6
 RBC, M/ul 8.5 11.1 8.7–10.5
 HGB, g/dl 12.9 15.4 12.2–16.2
 HCT,% 51.0 55.8 42–44
 MCV, fl 60.1 50.1 na
 MCH, pg 15.3 13.8 na
 MCHC 0.3 27.6 na
 Platelet count, K/ul 992.0 2043.0 100–1,000
Differential
Absolute/µl (%) Absolute/µl (%)
 Bands 0 (0.0) 0 (0.0) 0
 Polys 960 (38.0) 6,220 (42.0) 6.7–37.2
 Lymph 1,240 (49.0) 7,090 (48.0) 63–75
 Monos 250 (10.0) 1,030 (7.0) 0.7–2.6
 Eos 80 (3.0) 440 (3.0) 0.9–3.8
 Baso 0 (0.0) 0 (0.0) 0–1.5
Comments Polychromasia, +1 Slight polychromasia Platelet count inaccurate due to clumps
Small mammal panel
 Glucose mg/dl 196.0 170.0 106–278
 Urea nitrogen (BUN), mg/dl 24.0 30.0 19–34
 Calcium, mg/dl 10.6 10.1 9–12
 Total protein, g/dl 6.9 5.7 4.3–6.4
 Albumin, g/dl 3.5 3.2 2.0–4.7
 Alanine aminotransferase, U/l 43.0 47.0 26–120
 Aspartate aminotransferase, U/l 83.0 107.0 69–191
Principal histologic diagnoses Pituitary adenocarcinoma Histiocytic sarcoma Keratitis and corneal ulceration Polyarteritis Harderian gland adenoma Preputial adenitis and seminal vesiculitis Mild nephropathy

aSummarized from (58, 59).